Thu, Oct 23, 2014, 3:33 PM EDT - U.S. Markets close in 27 mins.


% | $
Quotes you view appear here for quick access.

Threshold Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • skibum1985 skibum1985 Aug 26, 2012 8:04 AM Flag

    Strategic Acquisition

    We don't want to see this happen anytime soon. A $12-$15 buyout would be a fraction of what the potential is even next year.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Thats true ski, but 55 pps would probably be the starting bid. After the OS comes out, buyout rumors will start to circulate again .

      • 1 Reply to daaytradenot159
      • smarting Aug 26, 2012 4:02 PM Flag

        I have stated on here many times before, a buyout is not the "best case scenario" for long term THLD shareholders. Though we as shareholders basically have little to no say in the matter, a buyout within the next 12 months will not allow us to be rewarded in the sense of realizing the true long term potential of this company. I agree with daay that bids to acquire THLD following release of positive O/S data from the 404 trial could be in the $30 to $60 range. Compare that to a market cap value of Threshold as we progress over the next 12 to 24 months with respect to NDA filing for TH-302 soon after release of O/S data (404 trial), EMA and FDA approval for soft tissue sarcoma (406 trial), positive trial results in our on-going trials for indications in Advanced Leukemias (407 trial currently in phase 1), positive results from phase 1/2 trials in solid tumors (401 and 402 trials), in addition to other indications such as Multiple Myeloma and Prostate. Putting a potential valuation on Threshold Pharma is a difficult one, but 15 to 20 times the per share price of today is not far fetched.

        Bullish on THLD...good luck to all,

2.98+0.01(+0.34%)3:31 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.